BR9708929A - Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos - Google Patents

Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos

Info

Publication number
BR9708929A
BR9708929A BR9708929A BR9708929A BR9708929A BR 9708929 A BR9708929 A BR 9708929A BR 9708929 A BR9708929 A BR 9708929A BR 9708929 A BR9708929 A BR 9708929A BR 9708929 A BR9708929 A BR 9708929A
Authority
BR
Brazil
Prior art keywords
processes
mammal
pharmaceutical composition
bacterial infection
compounds
Prior art date
Application number
BR9708929A
Other languages
English (en)
Inventor
Yat Sun Or
Richard F Clark
Zhenkun Ma
George Griesgraber
Leping Li
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/841,038 external-priority patent/US6075011A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR9708929A publication Critical patent/BR9708929A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
BR9708929A 1996-05-07 1997-05-06 Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos BR9708929A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64647796A 1996-05-07 1996-05-07
US08/841,038 US6075011A (en) 1996-05-07 1997-04-29 6-O-substituted erythromycin compounds and method for making same
PCT/US1997/007702 WO1997042206A1 (en) 1996-05-07 1997-05-06 6-o-substituted erythromycin compounds and method for making same

Publications (1)

Publication Number Publication Date
BR9708929A true BR9708929A (pt) 1999-08-03

Family

ID=27094941

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708929A BR9708929A (pt) 1996-05-07 1997-05-06 Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos

Country Status (12)

Country Link
EP (1) EP1007530B1 (pt)
AT (1) ATE310010T1 (pt)
AU (1) AU726075B2 (pt)
BR (1) BR9708929A (pt)
CA (1) CA2253330C (pt)
CZ (1) CZ351898A3 (pt)
DE (1) DE69734678T2 (pt)
DK (1) DK1007530T3 (pt)
ES (1) ES2252784T3 (pt)
IL (1) IL126625A0 (pt)
NZ (1) NZ332320A (pt)
WO (1) WO1997042206A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4472797A (en) * 1996-10-31 1998-05-22 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
JP2000198795A (ja) * 1996-10-31 2000-07-18 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
EP3589327A4 (en) * 2017-03-03 2022-04-06 Synovo GmbH NOVEL ANTI-INFECTION AND ANTI-INFLAMMATORY COMPOUNDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2782793B2 (ja) * 1988-06-15 1998-08-06 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Also Published As

Publication number Publication date
DE69734678T2 (de) 2006-08-17
CZ351898A3 (cs) 1999-04-14
AU726075B2 (en) 2000-10-26
DK1007530T3 (da) 2006-04-03
CA2253330A1 (en) 1997-11-13
ATE310010T1 (de) 2005-12-15
EP1007530B1 (en) 2005-11-16
EP1007530A1 (en) 2000-06-14
WO1997042206A1 (en) 1997-11-13
ES2252784T3 (es) 2006-05-16
DE69734678D1 (de) 2005-12-22
AU2998797A (en) 1997-11-26
NZ332320A (en) 2000-07-28
CA2253330C (en) 2006-07-25
IL126625A0 (en) 1999-08-17

Similar Documents

Publication Publication Date Title
TR199901127T2 (xx) Antibakteriyel etkili 6-O-ikameli ketolitler.
CA2253338A1 (en) 6-o-substituted erythromycins and method for making them
EP2295402A3 (en) Antibacterial agents
YU11699A (sh) 6-supstituisani ketolidi koji imaju antibakterijsko dejstvo, postupci za njihovo dobijanje i njihovi farmaceutski preparati
CA2292359A1 (en) Novel azalides and methods of making same
ATE398627T1 (de) C-2-modifizierte erythromycinderivate
HK1074447A1 (en) 6-11 bicyclic ketolide derivatives
CA2359708A1 (en) Ketolide antibiotics
WO2005000863A3 (en) 6, 11-4c-bicyclic 9a-azalide derivatives
WO2006063039A3 (en) 3, 6-bicyclolides
BR9708929A (pt) Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
WO2004096823A3 (en) Novel ketolide derivatives
WO2004087728A3 (en) 6,11-3c-bicyclic 9a-azalide derivatives
NO20002099L (no) 6,11-bro-erytromycinderivater
CA2307788A1 (en) 2-halo-6-o-substituted ketolide derivatives
WO2004096822A3 (en) Pyridyl substituted ketolide antibiotics
BG104340A (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
CA2483875A1 (en) 6,11 bicyclic erythromycin derivatives
WO1999011651A3 (en) 3-descladinose 6-o-substituded erythromycin derivatives
BG103985A (en) Multicyclic derivatives of erythromycin
CA2563965A1 (en) 6-0-substituted ketolides having antibacterial activity

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]